CD4 and neoplasm: We thus speculated that RHRT may induce the release of neoantigens by tumor cells that in turn stimulated the priming and expansion of neoantigen-specific T cells, represented by the boosted PD-1+ CD8+ and CD4+ T cells observed in the periphery.